Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0QB9L
|
||||
| Former ID |
DNC007243
|
||||
| Drug Name |
2-morpholino-6-(naphthalen-2-yl)-4H-pyran-4-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528738] | ||
| Formula |
C19H17NO3
|
||||
| Canonical SMILES |
C1COCCN1C2=CC(=O)C=C(O2)C3=CC4=CC=CC=C4C=C3
|
||||
| InChI |
1S/C19H17NO3/c21-17-12-18(23-19(13-17)20-7-9-22-10-8-20)16-6-5-14-3-1-2-4-15(14)11-16/h1-6,11-13H,7-10H2
|
||||
| InChIKey |
FNMVAZNGFWLDOQ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [528738] | |
| KEGG Pathway | Non-homologous end-joining | ||||
| Cell cycle | |||||
| NetPath Pathway | IL1 Signaling Pathway | ||||
| Reactome | Nonhomologous End-Joining (NHEJ) | ||||
| References | |||||
| Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
| Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.